Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma

Experimental and Molecular Pathology

Volumn 91, Issue 3, 2011, Pages 702-707

  Huang, Zhao Hui ^a   Hu, Yu ^a   Hua, Dong ^a   Wu, Yu Yu ^a   Song, Ming Xu ^a   Cheng, Zhi Hong ^a  

^a Soochow University   (China)

Author keywords

Diagnosis; DNA methylation; Hepatocellular carcinoma; Plasma; Restriction enzyme

Indexed keywords

GENOMIC DNA;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA METHYLATION; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GSTP1 GENE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MALE; ONCOGENE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PROGNOSIS; QUANTITATIVE ANALYSIS; RASSF1A GENE; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RESTRICTION MAPPING; SENSITIVITY AND SPECIFICITY; SFRP1 GENE; TUMOR SUPPRESSOR GENE;

ADULT; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; FEMALE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

NUCLEOPOLYHEDROVIRUS;

EID: 80053515231     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.08.004     Document Type: Article

References (25)

1. Chan K.C., et al. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma. Clinical Chemistry 2008, 54:1528-1536.
2. Chang H., et al. Methylation of tumor associated genes in tissue and plasma samples from liver disease patients. Experimental and Molecular Pathology 2008, 85:96-100.
3. Feng Q., et al. DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection. Experimental and Molecular Pathology 2010, 88:287-292.
4. Gagnon J.F., et al. Quantitative DNA methylation analysis of laser capture microdissected formalin-fixed and paraffin-embedded tissues. Experimental and Molecular Pathology 2010, 88:184-189.
5. Harder J., et al. Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver. International Journal of Cancer 2008, 122:2800-2804.
6. Hernandez-Vargas H., et al. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. PloS One 2010, 5:e9749.
7. Hua H., et al. Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzymes-based quantitative PCR for the detection of hepatocellular carcinoma. Experimental and Molecular Pathology 2011, 91:455-460.
8. Huang Z.H., et al. Quantitation of plasma circulating DNA in hepatocellular carcinoma using quantitative PCR and its potential clinical value. China Oncology 2010, 20:663-667.
9. Huang Z.H., et al. The evaluation and application of methylation-sensitive restriction enzymes-based quantitative PCR for DNA methylation detection. Zhonghua Bing Li Xue Za Zhi 2011, 40:263-265.
10. Iyer P., et al. Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients. Experimental and Molecular Pathology 2010, 88:107-111.
11. Lee S., et al. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. American Journal of Pathology 2003, 163:1371-1378.
12. Levenson V.V. DNA methylation as a universal biomarker. Expert Review of Molecular Diagnostics 2010, 10:481-488.
13. McCabe M.T., et al. Cancer DNA methylation: molecular mechanisms and clinical implications. Clinical Cancer Research 2009, 15:3927-3937.
14. Moribe T., et al. Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. International Journal of Cancer 2009, 125:388-397.
15. Nishida N., et al. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology 2008, 47:908-918.
16. Qureshi S.A., et al. Utility of DNA methylation markers for diagnosing cancer. International Journal of Surgery 2010, 8:194-198.
17. Shivapurkar N., Gazdar A.F. DNA methylation based biomarkers in non-invasive cancer screening. Current Molecular Medicine 2010, 10:123-132.
18. Su P.F., et al. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. International Journal of Cancer 2007, 121:1257-1264.
19. Tangkijvanich P., et al. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma. Clinica Chimica Acta 2007, 379:127-133.
20. Usadel H., et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Research 2002, 62:371-375.
21. Wang J., et al. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Clinical Biochemistry 2006, 39:344-348.
22. Wong I.H., et al. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Research 1999, 59:71-73.
23. Yang B., et al. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. American Journal of Pathology 2003, 163:1101-1107.
24. Yeo W., et al. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma. Liver International 2005, 25:266-272.
25. Zhang Y.J., et al. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clinical Cancer Research 2007, 13:2378-2384.